The Royal Pharmaceutical Society and Scottish Academy of Medical Royal Colleges co-hosted the NHS Education for Scotland annual virtual conference to discuss
the environmental impact of prescribing.
One of the conclusions drawn from the conference on Thursday (April 28) stressed on environmentally sustainable prescribing should be embedded in undergraduate
and postgraduate health care education.
Delegates at the session said they or their teams needed more education. They also needed more information and resources when prescribing to be able to consider
environmental issues.
Sharon Pfleger, Consultant in Pharmaceutical Public Health at NHS Highland, told the session: "There's a lot of work to be done to reduce carbon emissions. The
NHS has identified the use of metered-dose inhalers as its second biggest cause of carbon emissions as the propellant gases have significant global warming potential.
The Royal Pharmaceutical Society (RPS) Director for Scotland Clare Morrison participated in the panel discussion alongside representatives from other health
professional organisations on tackling the workforce crisis at the SNP conference in Aberdeen on 8 October.
At the conference, the Cabinet Secretary for Health and Social Care committed to achieving protected learning time for health professionals. Morrison welcomed the
Cabinet Secretary's statement as fantastic news for pharmacists across Scotland.
"RPS Scotland will follow up the discussion by writing to the Cabinet Secretary to request a meeting to discuss achieving protected learning time, the forthcoming
results of our workforce wellbeing survey, and positive examples of how pharmacy teams have improved the well-being of their teams," said the society.
Mental health has become a major concern worldwide and across all sectors,including pharmacy and pharmaceutical industry. The penetration of the issue exacerbated during the Covid-19 pandemic, due to mental fatigue, anxiety and most importantly the social distancing.
Therefore, building an environment of trust and comfort is utmost essential to understand and tackle mental health challenges, said panelists in a discussion on Mental Health And Wellbeing In The Workplace, held during the Pharmacy Business Diversity Conference on Thursday (December 9).Talking in context of workplace, Monika Misra, head of Employee Health and Wellbeing, Europe and MEA, said: "We really need to create an environment of trust where we a have the manager, really trying to understand the unique challenges and needs of the individual, but be also ensuring that the individual feels comfortable to open up and have that conversation with their manager."
Later this week I will be speaking at the Pharmacy Business Diversity Conference on a panel exploring LGBTQ+ inclusion in the workplace.
I came out as a gay man at 15 and have been out (openly gay) at work ever since. I've never knowingly suffered homophobia at work, and I know how lucky that makes me.
Too many LGBTQ+ people's experience of work is not as positive as mine.
Addressing microaggressions
When reflecting for the upcoming panel, I realised that, even for people who were not subjected to some of the awful examples I've heard about, working life can be exhausting.
Although microaggressions can seem trivial to those not on the receiving end, they create a culture where people feel the need to hide who they are and make work unwelcoming.
Most people can understand that shouting homophobic language across an office is wrong. Talking about microaggressions seems to be much more challenging, which is why addressing them in a workplace requires conscious and positive action.
The journey on building inclusive teams and increasing ethnic diversity and representation at all levels is never ending, said Sanjay Bhandari, chair at Kick It Out.
"I think you can set the direction but it's quite difficult to set the destination with these things," Bhandari, who is part of the government-sponsored Parker review into the ethnic diversity of UK boards said during a panel discussion on Inclusive Leadership held as part of the Pharmacy Business Diversity Conference on Thursday (December 9).
He said the aim of the review was to fix a destination like a milestone, it's not the ultimate destination.
Bhandari highlighted that "most organisations have not even started and so a good way of getting started was by the end of 2021 to have at least one British born director of colour on your board for the FTSE 100 (companies)."
The idea of the review is to "focus on that pathway and filling the hole inthedoughnut," Bhandari said.
David Webb, the Chief Pharmaceutical Officer for England, acknowledged that the "pressure in the system is high", but urged everyone to "keep our eye on the
design" of the NHS plan, adding that the "the objective is to bring the different parts of primary care together" in the patient interest.
Speaking during the opening keynote session at the the National Pharmacy Association (NPA) conference held on Thursday (13 October), he added that the NHS plan
intends to bring different parts of primary care together to help patients.
He said the new integrated care boards (ICBs) are a key strategic framework as they provide the "potential to form partnerships to deliver integrated services across
larger populations".
"ICBs will want to work with Local Pharmaceutical Committees to plan for the local population and the new community pharmacy clinical leads in ICBs, who have been
funded by NHS England, are there to advise."
He explained that once an ICB takes over the commissioning of pharmaceutical services (which they are all due to do by April 2023), it could use its funds to
commission a local enhanced service as an add on to an advanced service. For instance, a CVD risk assessment could be added to the blood pressure check service.
Leaders from across the pharmacy sector and trade bodies dwelled on the challenges faced by the pharmacists at the Sigma Conference held on Sunday (2 October).
"If the cost of carrying out regulation is higher than the benefits, it's time for all the bodies to sit together and talk on what can be adjusted accordingly,"
said Salim Jetha, Chairman, Avicenna.
Jetha highlighted the challenges faced by the independent pharmacy and also raised the concern about the 'level playing field' for pharmacists compared to GPs. He
said: "GPs get paid for energy cost, premises cost, the staffing cost. We don't get paid for that. So don't be misled by saying we are being exactly the same. Yes,
on paper we are, but in reality we are not. I think also the rules of engagement are different."
He called for better collaboration with GPs, and urged PSNC and other trade bodies to ensure a level playing field.
Janet Morrison, CEO, Pharmaceutical Services Negotiating Committee(PSNC), warned that the pressure in the sector is building up to a 'breaking point'.
It's time for pharmacists to get their technology forecasting hats on and be selective in choosing digital technologies, commented Prof James Woudhuysen, of
London South Bank University, at the National Pharmacy Association (NPA) Conference, Pharmacy Odyssey, held on Thursday (13 October).
In a session on 'Healthcare in tomorrow's digital environment', hosted by Fergus Walsh, Prof Woudhuysen opined that digitisation has its merit, but it's quite tricky,
and slower than we imagine.
"Mechanisation has a digital component that we can look to as a way out of the gloom of the moment. And in dispensing, labelling, prescribing, and many other features
of the conventional retail pharmacist, there's a lot that could be done for productivity and automation," he said.
Replying to a question on 'where are we at the digital front now and where can it go', Woudhuysen replied: "It's taken 20 years for the electronic prescription. It
was Tony Blair, who wanted every prescription electronic. The mishaps on repeat prescriptions and all the rest of it are still quite intense. So, we need to remember
that electronics is only as clever as software and then human input into it. There're still many mistakes.
Laura Wilson, Director of the Royal Pharmaceutical Society (RPS) in Scotland discussed the future of the pharmacy workforce with Michael Matheson,
Cabinet Secretary for Health and Social Care at the SNP conference.
The event, which took place on 17 October in Aberdeen, Scotland featured other health officials including Colin Poolman, Director of the Royal College of
Nursing; Kenryck Lloyd-Jones, Public Affairs and Policy Manager for Scotland, Chartered Society of Physiotherapy; and Chris Marshall, Deputy Editor at Holyrood
Communications.
The Scottish government has recently unveiled its national workforce strategy for health and social care, laying out its plans for achieving recovery, growth,
and transformation.
Wilson highlighted the challenges and opportunities for the pharmacy workforce in Scotland to attract potential pharmacists into the profession and encourage
them to stay within the profession.
"This was a great opportunity to discuss with the Cabinet Secretary the challenges which exist for the pharmacy workforce in Scotland and to highlight some of
the solutions which need to be implemented to ensure a pharmacy workforce in Scotland which is fit for the future," she said.
Speaking at the SIGMA Conference 2023, Dr Leyla Hannbeck, CEO of the Association of Independent Multiple Pharmacies (AIMp), spoke about the increasing
number of prescriptions, lack of funding and other existing challenges.
Leyla explained how the pharmacy sector is facing immense challenges which are disrupting the delivery of services as well as impacting its growth.
She further spoke about the hub and spoke model, and how it is unable to solve the issues.
"Community pharmacies are clogged with prescription volume, and this is preventing them from supporting the wider NHS as well as offering services," she said.
She said that the prescription volumes have rocketed, while the number of pharmacies in England has declined from 11, 522 in the year 2021-22 to 11, 414 in 2022-23.
When it comes to Company Chemists' Association (CCA) pharmacies, there has been a loss of 1055 branches from 2022 to 2023.
MP Steve Brine, the chair of the health and care committee, said that the healthcare in the UK "doesn't work without pharmacy".
The inquiry focuses on addressing current issues, particularly around the "funding model, digital infrastructure and workforce recruitment, training and retention."
Brine said at the Sigma annual conference on Sunday, that he wants to "focus on the sector", and "drill down into some of the challenges and potential" that lies
ahead.
"The Health and Social Care Committee, we think about much of our work through the lens of pharmacy, what role it plays, the quality of care that it delivers, and
the potential for it to do more," said Brine.
He further said that he wants to "build on the groundwork" and to "cover as many of the different pharmacy services within the pharmacy sector as we can, so pharmacy
in our communities, in hospitals and general practice".
After struggling with COVID, Hemant Petal is back to good health, and now he is on a mission to reduce "health inequalities".
Speaking at the SIGMA Conference 2023, he spoke about his new role as Clinical Lead, Health Inequalities and Population Health Management, SE Essex Alliance,
Essex ICB.
"So, my new role is outside pharmacy, nothing to do with pharmacy. But it is important, I feel that I share some of my insights about the work that I'm doing that
might benefit you," he said.
Elaborating on the role of integrated care boards (ICBs), he said that they are designed to enhance coordination and collaboration across different healthcare
providers and settings.
The representatives from hospitals, community services, retail and social care meet on a monthly basis to "look at where there are issues to be resolved, perhaps
what can be done to improve the healthcare services."
Duncan Rudkin, the CEO of the General Pharmaceutical Council (GPhc) has highlighted the importance of strengthening pharmacy governance to provide clarity
around how pharmacies are organised and managed.
This will ensure that patients and the public continue to receive safe and effective pharmacy care, he said while speaking at the annual Sigma Conference in
London on Sunday (5 November).
According to him, there could be rules that outlined the essential roles and responsibilities of responsible pharmacists, and professional standards for
responsible pharmacists, superintended pharmacists and chief pharmacists.
He also announced that the GPhC will be shortly launching a consultation to integrate a new set of standards for the statutory role of hospital chief
pharmacists "which up until recently has never been recognised in law." It is expected to be launched by early January 2024.
However, Duncan, emphasised that they cannot start the work on standards for responsible and superintendent pharmacists until they know the government plans
in relation to supervision.
"Because of course, the responsible pharmacists' regime, and the supervision regime are in many ways intertwined, and can't certainly be looked at separately.
At the Future of Britain Conference 2024, the newly appointed Secretary of Health and Social Care, (DHSC) Wes Streeting, stated that "Labour's DNA is in
the NHS".
He also called for a long-term approach to reform the broken health sector and the integration of artificial intelligence (AI) to steer the healthcare system
towards sustainability and growth.
Hosted by Tony Blair Institute for Global Change and My Life My Say today, Tuesday, 9, Streeting discussed the plans to fix the healthcare system and role of
Artificial Intelligence (AI) in "making the right choices" by bringing in three essential shifts in the healthcare.
Criticising the previous Conservative administration for leaving "massive burning deck issues" due to constant reshuffling within the Department of Health and
Social Care (DHSC), Streeting lamented that this "instability" and "indecisions" have made comprehensive reform even more pressing.
Drawing inspiration from Chancellor Rachel Reeves' speech on economic growth, Streeting stressed the interconnectedness of health and economic prosperity.
Walgreens Boots Alliance, the parent company of Boots UK, has begun a strategic review of its business in the United Kingdom, chief executive officer Rosalind Brewer said on Tuesday (January 11) - as the pharmacy chain tries to renew its focus on US healthcare.
Boots has over 2,200 stores across the UK, which include pharmacies, health and beauty stores, among others, according to the chain's website.
"This review is very much in line with our renewed priorities and strategic direction. In particular, our increased focus on US healthcare. While the process is at an exploratory stage, we do expect to move quickly," Brewer said at the JP Morgan Healthcare Conference.
The review comes at a time when the company, which was formed in 2014 after the acquisition of stake in Alliance Boots by Walgreens, moves beyond its drugstores with its investments in two smaller healthcare providers, CareCentrix and VillageMD.
It is not sustainable to give Covid-19 booster shots every three to six in the long term, Britain's chief scientific adviser said on Tuesday (January 4), even though the booster rollout is needed in the short term to combat the Omicron variant.
"It would be a situation that isn't tenable to say everyone's going to need to be having another vaccine every three or six months.
"That's not the long-term view of where this goes to," Patrick Vallance said at a news conference, adding that annual booster shots against Covid-19 might be necessary, similar to flu shots.
Alliance Healthcare, the UK's largest pharmaceutical wholesaler, has pledged to support the global efforts to cut carbon emissions, as set out at the recent UN Climate Change Conference, COP26.
The company's pledge is in line with its aim to create "healthier futures and thebusiness", on which it has been working on for years.
It aims to become the most sustainable independent full-line pharmaceutical wholesaler in the UK by 2030, ensuring to remain the sustainable partner of choice for its customers and manufacturers.
The European Commission said on Wednesday it would allocate 1.23 billion euros ($1.3 billion) to mental health initiatives across the 27-member European Union
and make mental health a pillar of health policy.
"Today marks a new beginning for a comprehensive, prevention-oriented and multi-stakeholder approach to mental health at EU level," Stella Kyriakides, EU Commissioner
for health and food safety, said in a statement.
"We need to break down stigma and discrimination so that those in need can reach out and receive the support they need. It is OK not to be OK, and it is our duty to
ensure that everyone asking for help has access to it."
The Commission said mental health problems already impacted around 84 million people before the COVID-19 pandemic with an economic cost of about 600 billion euro a
year, or 4% of the bloc's GDP.
The situation has deteriorated since the pandemic with the war in Ukraine, climate change anxiety and the rising cost of living due to soaring inflation.
At a press conference, Commission vice-president Margaritis Schinas called it a "silent epidemic" and said the topic was the last piece in the European Health Union
"puzzle".
The Health and Social Care Secretary Steve Barclay has proposed a new £30 million fund to speed up the adoption of innovative medical technology in the NHS.
He confirmed the plan today at the Conservative Party Conference 2023 in Manchester.
Mr Barclay said that virtual wards will help healthcare professionals embrace new technology to improve patient care.
He said: "It is vital that clinicians have access to the latest technology to save staff time, deliver high-quality care and help cut waiting lists - one of the
government's top five priorities.
"This investment will see the latest tech innovations rolled out across the NHS. From virtual ward beds to wearable medical devices, patients will be better
supported, and we will ease pressures on hospitals this winter.
"We're preparing for this winter earlier than ever before including delivering thousands more hospital beds and hundreds of new ambulances."
Six pharmacists based in Scotland were acknowledged by the profession this week during a celebratory event held at the home of Scottish pharmacy, the RPS
building on Melville Street, Edinburgh.
Four pharmacists have been officially conferred with Fellowships of RPS for their significant contributions to the practice of pharmacy. The recipients are:
Richard Lowrie
Lynn Morrison
Deborah Steven
Audrey Thompson
Two pharmacists, Katherine Davidson and Emily Kennedy, have attained accreditation as consultant pharmacists. This designation is granted in recognition of their
demonstrated expertise at a senior level, spanning clinical practice, leadership, research, and education, RPS said in a statement.